Weighing Generic Litigation In The ITC

Pharmaceutical companies are not strangers to the U.S. International Trade Commission, although they generally have appeared as respondents, such as in a recent investigation initiated by a Florida patent-holding company against...

Already a subscriber? Click here to view full article